Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

The search

Query: GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
From: UniProt P01275, residues 98 to 128
Search: Protein → Patent proteins · Automatic (Smith-Waterman)
Set: Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran: 2026-11-12
Found: 5,000 sequences, 3,061 publications, 1,851 families

Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.

Patents

3,061 publications in 1,851 families match these filters.

JP 2021520346-A2021-08-19

NOVEL GLP-1 ANALOGUE

Sun Pharmaceutical Industries Ltd

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020210102345-A2021-08-19

PEPTIDE BINDER

SANOFI

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020210102346-A2021-08-19

INSULIN CONJUGATES

SANOFI

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
WO 2021160813-A12021-08-19

OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF

FERRER INT

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020210103265-A2021-08-23

A novel pharmaceutical composition for treating non-alcoholic steatohepatitis

Genexine, Inc.

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11098102-B22021-08-24

Insulin conjugates

SANOFI

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
EP 3875465-A12021-09-08

METHOD FOR MODIFICATION OF POLYPETIDE AND USES

XIANGYA HOSPITAL CENTRAL SOUTH UNIV

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
EP 3875476-A12021-09-08

GLP-1 POLYPEPTIDE HAVING GLP-1 RECEPTOR AGONIST ACTIVITY AND USES THEREOF

LIU JIANNING

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3875476-A12021-09-08
- KR 1020240044545-A2024-04-04
US 11117946-B22021-09-14

Method for preparing glucagon-like peptides

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
EP 3882263-A12021-09-22

GLUCAGON-DERIVED PEPTIDE AND USE THEREOF

TIANJIN INSTITUTE OF PHARMACEUTICAL RES CO LTD

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020210115239-A2021-09-27

A novel pharmaceutical composition for treating metabolic syndrome and diseases related thereto

SL METAGEN

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020210116322-A2021-09-27

A novel bispecific protein and use thereof

SL METAGEN

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210116322-A2021-09-27
- KR 1020220005622-A2022-01-13
US 11130793-B22021-09-28

GLP-1/GLP-2 dual agonists

Zealand Pharma A/S

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11136360-B22021-10-05

Fusion proteins comprising a Mtu delta-I-CM intein variant and methods of protein purification

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11136364-B22021-10-05

Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising same

YUHAN CORPORATION

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11141464-B22021-10-12

GLP-1 polypeptide having GLP-1 receptor agonist activity and use thereof

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11155577-B22021-10-26

Thiol-ene based peptide stapling and uses thereof

University of Utah Research Foundation

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11160836-B22021-11-02

Transgenic pig islets and uses thereof for treating diabetes

UNIVERSITE CATHOLIQUE DE LOUVAIN

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
WO 2021219710-A12021-11-04

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE

NOVO NORDISK AS

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2021219710-A12021-11-04
- JP 2023524695-A2023-06-13
US 11167014-B22021-11-09

Solid glp-1 derivative compositions for oral administration

Novo Nordisk A/S

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020210137093-A2021-11-17

A POLYPEPTIDE MOLECULE AND APPLICATION THEREOF

SUNSHINE LAKE PHARMA CO., LTD

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210137093-A2021-11-17
- JP 2022522787-A2022-04-20
US 11179440-B22021-11-23

Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis

YUHAN CORPORATION

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11186608-B22021-11-30

Solid phase synthesis of acylated peptides

Bachem Holding AG

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2021536249-A2021-12-27

ALLOGENEIC CELL COMPOSITIONS AND METHODS OF USE

Poseida Therapeutics Inc

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
```
Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
          |||||||||||||||||||||||||||||||
Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
```
31 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/727498.
- JP 2021536249-A2021-12-27
- JP 2025028160-A2025-02-28
US 11208451-B22021-12-28

Protein and protein conjugate for diabetes treatment, and applications thereof

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022511567-A2022-01-31

Insulin conjugate

Sanofi

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022512908-A2022-02-07

GLP-1 polypeptide having GLP-1 receptor agonist activity and use thereof

Jianning LIU

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11242373-B22022-02-08

GLP-1 analogues

Sun Pharmaceutical Industries Limited

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022513775-A2022-02-09

Peptide Binder

Sanofi

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11253574-B22022-02-22

Fusion proteins and methods of use

Eli Lilly and Company

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022516509-A2022-02-28

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Coherus Biosciences Inc

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11260081-B22022-03-01

Engineered parasites for delivering protein to the central nervous system (CNS)

Ramot at Tel-Aviv University Ltd. and The Universitv Court of the University of Glasgow

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
```
Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
          |||||||||||||||||||||||||||||||
Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
```
31 of 31 identical, no gaps.
KR 1020220027204-A2022-03-07

PHARMACEUTICAL COMPOSITIONS FOR GLUCAGON AND GLP-1 CO-AGONIST PEPTIDES

MEDIMMUNE LIMITED

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020220034811-A2022-03-18

METALLOTHIONEIN ANTIBODIES AND THEIR USE

UNIVERSITY OF CONNECTICUT

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220034811-A2022-03-18
- JP 2022542805-A2022-10-07
KR 1020220039790-A2022-03-29

FGF21 FC FUSION PROTEIN, GLP-1 FC FUSION PROTEIN, AND COMBINATION THERAPEUTIC AGENT COMPRISING SAME AND USE THEREOF

AMPSOURCE BIOPHARMA SHANGHAI INC

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220039790-A2022-03-29
- JP 2022542151-A2022-09-29
US 11291693-B22022-04-05

Bacteria engineered to treat metabolic diseases

Synlogic Operating Company, Inc.

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 11291693-B22022-04-05
- US 11896627-B22024-02-13
JP 2022521551-A2022-04-08

VARIANT NUCLEIC ACID LIBRARIES FOR GLP1 RECEPTOR

TWIST BIOSCIENCE CORPORATION

Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 62/810377.
- JP 2022521551-A2022-04-08
- US 11492727-B22022-11-08
- JP 2024156678-A2024-11-06
US 11304992-B22022-04-19

Inhalable dry powder pharmaceutical composition

MANNKIND CORPORATION

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022523972-A2022-04-27

GROWTH DIFFERENTIATION FACTOR 15 COMBINATION THERAPY

AMGEN INC

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/815866.
- JP 2022523972-A2022-04-27
- JP 2024156886-A2024-11-06
JP 2022524081-A2022-04-27

HUMAN CARBONIC ANHYDRASE 2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

OBSIDIAN THERAPEUTICS INC

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
```
Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
          |||||||||||||||||||||||||||||||
Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
```
31 of 31 identical, no gaps.
JP 2022527825-A2022-06-06

IONIC LIQUIDS FOR DRUG DELIVERY

PRESIDENT AND FELLOWS OF HARVARD COLLEGE

Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- JP 2022527825-A2022-06-06
- KR 1020220104766-A2022-07-26
- KR 1020240082406-A2024-06-10
- JP 2025069232-A2025-04-30
KR 1020220092446-A2022-07-01

A combination therapy of an insulinotropic peptide and GLP-2 for preventing or treating short bowel syndrome

HANMI PHARM. CO., LTD

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022532332-A2022-07-14

Fusion protein for treatment of metabolic disease

ZHEJIANG DOER BIOLOGICS CORPORATION

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022533066-A2022-07-21

POLYPEPTIDE DERIVATIVE AND PREPARATION METHOD THEREOF

NINGBO KUNPENG BIOTECH CO LTD

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
US 11400116-B22022-08-02

Systems and methods for targeting cancer cells

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE TRUSTEES OF PRINCETON UNIVERSITY and THE SIMONS FOUNDATION INC.

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
```
Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
          |||||||||||||||||||||||||||||||
Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
```
31 of 31 identical, no gaps.
KR 1020220110506-A2022-08-08

COMBINATION THERAPY USING GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY

MEDIMMUNE, LLC

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220110506-A2022-08-08
- JP 2023505126-A2023-02-08
KR 1020220112817-A2022-08-11

A METHOD OF FORMING A CONJUGATE OF A SULFONAMIDE AND A POLYPEPTIDE

SANOFI

Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220112817-A2022-08-11
- JP 2023505814-A2023-02-13
KR 1020220119730-A2022-08-30

INSULIN DERIVATIVE

Gan & Lee Pharmaceuticals Co., Ltd

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
KR 1020220119731-A2022-08-30

LONG-ACTING GLP-1 COMPOUND

Gan & Lee Pharmaceuticals Co., Ltd

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.
JP 2022539200-A2022-09-07

PHARMACEUTICAL COMPOSITIONS FOR GLUCAGON AND GLP-1 CO-AGONIST PEPTIDES

MEDIMMUNE LIMITED,Ana Lucia Gomes dos Santos

Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
31 of 31 identical, no gaps.

GLP-1, a diabetes hormone

The search

Patents

Family of 2

Family of 2

Family of 2

Family of 2

Family of 2

Family of 2

Family of 2

Family of 2

Family of 3

Family of 2

Family of 4

Family of 2

Family of 2